That means that an RNA virus such as H5N1 is particularly good at evolving to infect new species. But influenza viruses have another tool that makes them still more dangerous: an ability to swap ...

A recent study published in Nature Communications by researchers at the National Institute of Allergy and Infectious Diseases (NIAID) and collaborators evaluated a replicating RNA (repRNA) vaccine ...

The Indian Council for Medical Research (ICMR) is working to develop an indigenous vaccine against the H5N1 bird flu virus, ...

Its alert to doctors and hospitals follows a few rare but mysterious bird flu cases in the US – including, most recently, a child in San Francisco confirmed to have had H5N1 influenza – that ...

With cases of avian influenza A(H5N1) continuing to rise among cattle and humans in the US, scientists and government health officials are preparing for the potential of the virus adapting to ...

RNA polymerase is an enzyme that is responsible for copying a DNA sequence into an RNA sequence, duyring the process of transcription. As complex molecule composed of protein subunits, RNA ...

SAN DIEGO, January 10, 2025--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development ...

Each nucleocapsid protein-encapsidated RNA segment, together with its heterotrimeric polymerase, constitutes a viral ribonucleoprotein complex. Although consisting of only eight genomic segments ...

STP702 has been shown to be effective against H5N1 (avian flu ... dsRNA: Double-stranded RNA; pre-miRNA: Precursor miRNA; pri-miRNA: Primary miRNA; RISC: RNA-induced silencing complex; UTR ...

Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company ... also known as LUNAR-H5N1, for active immunization to prevent ...